References
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 1952; 40: 346
- Astrup T., Alkjærsig K., Soardi F. Partial purification of the trypsin inhibitor in urine. Scand. J. clin. Lab. Invest. 1959; 11: 181
- Astrup T., Nissen U., Assay of plasmin and urokinase (in preparation).
- Biezenski J. J., Moore H. C. Fibrinolysis in normal pregnancy. J. clin. Path. 1958; 11: 306
- Blix S. The effectiveness of activators in clot lysis. with special reference to fibrinolytic therapy. Acta med. scand. 1962; 172: 10, Suppl. no. 386
- Cliffton E. E. An evaluation of the antiproteolytic reaction of serum as a test for malignant neoplasia. J. nat. Cancer Inst. 1950; 11: 33
- Correll J. T., Sjoerdsma A. Inhibition of a human fibrinolytic system by normal and pathological sera. Proc. Soc. exp. Biol. (N.Y.) 1962; 111: 274
- Faarvang H. J. Relation between pituitary-adrenal system and excretion of trypsin inhibitor in urine. Ibid. 1958; 98: 89
- Faarvang H. J. The excretion of trypsin inhibitor in urine during normal pregnancy. Acta Endocr. (Kbh.) 1959; 31: 117
- Faarvang H. J., Lauritsen O. S. Relationship between scrum concentration and urinary output of trypsin inhibitor (hyaluronidase inhibitor) during operative stress. Enzymol. Biol. Clin. 1962; 1: 189
- Faarvang H. J., Lauritsen O. S. Increase of trypsin inhibitor in serum during pregnancy. Nature (Lond.) 1963, in press.
- Giilman Th., Naidoo S. S., Hathorn M. Plasma fibrinogen activity in pregnancy. Lancet 1959; 2: 70
- Gormsen J. Fibrinolytic activity. Inhibition of plasminogen activation. Acta med. scand. 1962; 172: 657
- Gräfenberg E. Der Antitrypsingehalt des müterlichen Blutserums während der Schwangerschaft. Münch, med. Wschr. 1909; 56: 702
- Guest M. M. Profibrinolysin. antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject. J. clin. Invest. 1954; 33: 1553
- Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta physiol. scand. 1952; 27: 371
- Naidoo S. S., Hathorn M., Gillman T. Fibrinolytic and antifibrinolytic activity in pregnancy. J. clin. Path. 1960; 13: 224
- Nilsson I. M., Bjorkman S. E., Andersson L. Clinical experiences with α-aminocaproic acid as an antifibrinolytic agent. Acta med. scand. 1961; 170: 487
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
- Phillips L. L., Skrodelis V. The fibrinolytic enzyme system in normal. hemorrhagic and disease states. J. clin. Invest. 1958; 37: 965
- Rasmussen J. Mechanisms and side effects in thrombolysis. Thrombolytic Activity and Related Phenomena, I. S. Wright, F. Koller, F. Strculi. Schattauer Verlag, Stuttgart 1960; 189, (Editors:)Transactions of the Conference at Princeton.
- Ratnoff O. D., Colopy J. E., Pritchard J. A. The blood-clotting mechanism during normal parturition. J. Lab. clin. Med. 1954; 44: 408
- Ruckstuhl L., Bellet S., Sandberg H., Gelber L. Changes in fibrinolytic parameters during the course of normal pergnancy. Amer. J. Obstet. Gynec. 1962; 84: 424
- Sgouris J. T., Inman J. K., McCall K. B., Anderson H. D. The evaluation of “fibrinolytic” preparations. Vox Sang. (Basel) 1961; 6: 53
- Waldvogel M., Marvin H. X., Wells B. H. Determination of serum antitrypsin in the study of malignant neoplasia. Proc. Soc. exp. Biol. (N.Y.) 1949; 72: 100